Four-channel asymmetric Real-Time PCR hybridization probe assay: A rapid pre-screening method for critical BCR-ABL kinase domain mutations-Reference-Cited by-同舟云学术

Four-channel asymmetric Real-Time PCR hybridization probe assay: A rapid pre-screening method for critical BCR-ABL kinase domain mutations

Published:2012-03 Issue:4-5 Volume:45 Page:345-351
ISSN:0009-9120
Container-title:Clinical Biochemistry
language:en
Short-container-title:Clinical Biochemistry

Author:

Martinez-Serra Jordi,Gutiérrez Antonio,Marcús Toni F.,Soverini Simona,Amat Juan Carlos,Navarro-Palou María,Ros Teresa,Bex Teresa,Ballester Carmen,Bauça Josep Miquel,SanFelix Sara,Novo Andrés,Vidal Carmen,Santos Carmen,Besalduch Joan

Publisher

Elsevier BV

Subject

Clinical Biochemistry,General Medicine

Reference15 articles.

1. What is Imatinib-resistant chronic myeloid leukemia? Identifying and managing loss of response;Zeidan;Clin Adv Hematol Oncol,2008

2. Detection of BCR-ABL mutations in patients with CML treated with Imatinib is virtually always accompanied by clinical resistance, and mutations in the ATP phosphate-binding loop (p-loop) are associated with a poor prognosis;Branford;Blood,2003

3. Resistance to tumor specific therapy with Imatinib by clonal selection of mutated cells;Muller;Dtsch Med Wochenschr,2002

4. BCR-ABL kinase domain mutation analysis in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors: recommendations from an expert panel on behalf of European LeukemiaNet;Soverini;Blood,2011

5. Molecular basis explanation for Imatinib resistance of BCR-ABL due to T315I and p-loop mutations from molecular dynamics simulations;Lee;Cancer,2008

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Deep sequencing of BCR-ABL1 kinase domain mutations in chronic myeloid leukemia patients with resistance to tyrosine kinase inhibitors;Leukemia & Lymphoma;2018-07-02

2. Clinical impact ofABL1kinase domain mutations andIKZF1deletion in adults under age 60 with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL): molecular analysis of CALGB (Alliance) 10001 and 9665;Leukemia & Lymphoma;2016-02-18

3. Rapid genotyping using pyrene−perylene locked nucleic acid complexes;Artificial DNA: PNA & XNA;2013-04